SCHEMBL27156306

SCHEMBL27156306

O=C(O)c1c(C(=O)O)c2c(Br)cc3ccccc3n2c1C(=O)c1ccc(Br)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKR1C3 P42330 1/20 0.43
▸ FNTA P49354 2/20 0.43
▸ FNTB P49356 2/20 0.43
▸ POLB P06746 3/20 0.39
▸ MAPT P10636 3/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ TP53 P04637 2/20 0.39
▸ KMT2A Q03164 4/20 0.37
▸ HAO1 Q9UJM8 1/20 0.35
▸ DAO P14920 1/20 0.35
▸ MEN1 O00255 3/20 0.34
▸ MCL1 Q07820 1/20 0.34
▸ ALDH1A1 P00352 3/20 0.33
▸ LMNA P02545 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ MGAM O43451 1/20 0.33
▸ F12 P00748 1/20 0.33
▸ AMY1A P0DUB6 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ SI P14410 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27156314 0.94 DAO (0.37) AKR1C3FNTAFNTBMAPTSMN1; SMN2
SCHEMBL27156303 0.91 NPC1 (0.37) AKR1C3FNTAFNTBPOLBMAPT
SCHEMBL27156307 0.91 NR4A1 (0.42) FNTAFNTBPOLBMAPTSMN1; SMN2
SCHEMBL27156310 0.88 TRPA1 (0.37) FNTAFNTBPOLBKMT2AHAO1
SCHEMBL27156311 0.88 RAB9A (0.40) POLBMAPTSMN1; SMN2KMT2AMEN1
SCHEMBL30816073 0.84 MAPT (0.41) FNTAFNTBPOLBMAPTSMN1; SMN2
SCHEMBL28458417 0.79 MAPT (0.36) MAPTSMN1; SMN2KMT2AHAO1DAO
SCHEMBL30816138 0.79 HPGD (0.41) MAPTSMN1; SMN2KMT2AMEN1ALDH1A1
SCHEMBL27181988 0.78 AKR1C3 (0.42) AKR1C3FNTAFNTBPOLBMAPT
SCHEMBL27156301 0.78 MEN1 (0.39) POLBMAPTKMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11919900-B1 1-substituted benzoyl-4-bromopyrrolo[1,2-a]quinoline-3-carboxylate derivatives as antitubercular agents King Faisal University (SA) 2024-03-05 — — US claimed
US-11919900-B1 1-substituted benzoyl-4-bromopyrrolo[1,2-a]quinoline-3-carboxylate derivatives as antitubercular agents King Faisal University (SA) 2024-03-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11919900-B1 1-substituted benzoyl-4-bromopyrrolo[1,2-a]quinoline-3-carboxylate derivatives as antitubercular agents BRD4, BET1, TALDO1 AKR1C3 2520/4885FNTA 720/4885FNTB 79/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback